Avicenna Alliance Welcomes SILICA to Advance the Future of Artificial Data and In Silico Medicine

SILICA is a multidisciplinary alliance dedicated to promoting the development and use of artificial and synthetic health data in France and Europe. Bringing together researchers, healthcare institutions, patient representatives, industry, and data producers, SILICA works to advance methodologies, support regulatory developments, and foster a common understanding of emerging evidence-generation approaches.

As a recognized partner of international health authorities, SILICA is helping shape the future of data-driven medicine by promoting the use of artificial data in clinical research, AI development, and health product evaluation.

“The collaboration between SILICA and the Avicenna Alliance will further strengthen the convergence of artificial data and in silico methods, helping accelerate medical innovation and improve patient access to safer, more effective, and more affordable healthcare solutions”, said Jean Louis Fraysse, Co-President, SILICA.

“We are delighted to welcome SILICA, with their large expertise in synthetic data, vast knowledge of the pharmaceutical industry and large network in France, to the Avicenna Alliance community. We look forward to working together to advance the future of healthcare innovation”, added Thierry Marchal, President & Secretary General, Avicenna Alliance.